Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Baghdad is all atwitter over the P-5+1 talks with Iran beginning today. A sandstorm kept many European and Western diplomats from landing, but the Iranians were out in full force, with Iranian negotiator Saeed Jalili leading the way.
This study attempts to ascertain whether registered medicines perform better in simple quality tests than those that are either not registered or not known to be registered.
A significant portion of antimalarial drugs in Africa have been illegally diverted from the public sector, where they were intended to be dispensed free of charge in public health facilities, to the private sector.
The Financial Stability Oversight Council (FSOC) recently released two studies as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act.
American Enterprise Institute economist Peter Wallison explains why the recent JP Morgan losses are proof that the Volcker Rule is unworkable and should be abandoned.
Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent.





